{"transactions":[{"id":727532,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-24T21:14:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":30700,"derivative":{"exercise_price":0.98,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0001774807-26-000005","document":"form4-06242026_090645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000177480726000005/form4-06242026_090645.xml","form_type":"4"}},{"id":727531,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:14:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":11497,"source":{"system":"sec-edgar","filing":"0001774807-26-000005","document":"form4-06242026_090645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000177480726000005/form4-06242026_090645.xml","form_type":"4"}},{"id":915908,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-07T02:30:03.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":77156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the achievement of performance stock units (\"PSUs\") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person."}],"balance_after":774749,"source":{"system":"sec-edgar","filing":"0001213900-26-013406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026013406/ownership.xml","form_type":"4"}},{"id":929908,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:30:29.000Z","date":"2026-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":27306,"price":7.27,"value":198514.62,"ownership":{"direct":true},"balance_after":697593,"source":{"system":"sec-edgar","filing":"0001213900-26-008478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026008478/ownership.xml","form_type":"4"}},{"id":929907,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:30:29.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":225900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":724899,"source":{"system":"sec-edgar","filing":"0001213900-26-008478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026008478/ownership.xml","form_type":"4"}},{"id":935276,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-01-20T14:28:12.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":false,"shares":29585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date."}],"balance_after":411245,"derivative":{"exercise_price":3.38,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":29585},"source":{"system":"sec-edgar","filing":"0001213900-26-005425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026005425/ownership.xml","form_type":"4"}},{"id":935275,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T14:28:12.000Z","date":"2026-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":22665,"price":6.78,"value":153668.7,"ownership":{"direct":true},"balance_after":498999,"source":{"system":"sec-edgar","filing":"0001213900-26-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026005425/ownership.xml","form_type":"4"}},{"id":935274,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T14:28:12.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":true,"shares":29585,"price":3.38,"value":99997.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made."}],"balance_after":521664,"source":{"system":"sec-edgar","filing":"0001213900-26-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026005425/ownership.xml","form_type":"4"}},{"id":935273,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T14:28:12.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":17417,"price":7.15,"value":124531.55,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error."}],"balance_after":492079,"source":{"system":"sec-edgar","filing":"0001213900-26-005425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026005425/ownership.xml","form_type":"4"}},{"id":961938,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-12-20T02:30:16.000Z","date":"2025-12-18","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":370000,"derivative":{"exercise_price":4.43,"expiration_date":"2033-01-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-25-124063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025124063/ownership.xml","form_type":"4"}},{"id":961937,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-20T02:30:16.000Z","date":"2025-12-18","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":12,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":509496,"source":{"system":"sec-edgar","filing":"0001213900-25-124063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025124063/ownership.xml","form_type":"4"}},{"id":961936,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-20T02:30:16.000Z","date":"2025-12-18","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":4.43,"value":132900.0,"ownership":{"direct":true},"balance_after":539496,"source":{"system":"sec-edgar","filing":"0001213900-25-124063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025124063/ownership.xml","form_type":"4"}},{"id":1017512,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-16T22:49:13.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":38381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest in three equal consecutive annual installments on October 14, 2026, October 14, 2027, and October 14, 2028, subject to the Reporting Person's continuous service to the Company."}],"balance_after":38381,"derivative":{"exercise_price":1.11,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":38381},"source":{"system":"sec-edgar","filing":"0001774807-25-000005","document":"form4-10162025_101009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000177480725000005/form4-10162025_101009.xml","form_type":"4"}},{"id":1017511,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T22:49:13.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":6397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units shall vest in three equal consecutive annual installments on October 14, 2026, October 14, 2027, and October 14, 2028."}],"balance_after":6397,"source":{"system":"sec-edgar","filing":"0001774807-25-000005","document":"form4-10162025_101009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000177480725000005/form4-10162025_101009.xml","form_type":"4"}},{"id":1041362,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-09-13T01:45:07.000Z","date":"2025-09-12","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":216667,"derivative":{"exercise_price":3.47,"expiration_date":"2034-01-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-087374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025087374/ownership.xml","form_type":"4"}},{"id":1041361,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-13T01:45:07.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":13,"value":650000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":509496,"source":{"system":"sec-edgar","filing":"0001213900-25-087374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025087374/ownership.xml","form_type":"4"}},{"id":1041360,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-13T01:45:07.000Z","date":"2025-09-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.47,"value":173500.0,"ownership":{"direct":true},"balance_after":559496,"source":{"system":"sec-edgar","filing":"0001213900-25-087374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025087374/ownership.xml","form_type":"4"}},{"id":1041358,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-13T01:31:43.000Z","date":"2025-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21225,"price":11.66,"value":247483.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to an inadvertent administrative error."}],"balance_after":509496,"source":{"system":"sec-edgar","filing":"0001213900-25-087371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025087371/ownership.xml","form_type":"4"}},{"id":1183043,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-04-02T11:00:03.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":59170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date."}],"balance_after":440830,"derivative":{"exercise_price":3.38,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":59170},"source":{"system":"sec-edgar","filing":"0001213900-25-027598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025027598/ownership.xml","form_type":"4"}},{"id":1183042,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T11:00:03.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":59170,"price":3.38,"value":199994.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made."}],"balance_after":530721,"source":{"system":"sec-edgar","filing":"0001213900-25-027598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025027598/ownership.xml","form_type":"4"}},{"id":1297425,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-23T02:11:40.000Z","date":"2025-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":23977,"price":12.17,"value":291800.09,"ownership":{"direct":true},"balance_after":471551,"source":{"system":"sec-edgar","filing":"0001213900-25-005675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025005675/ownership.xml","form_type":"4"}},{"id":1297424,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-23T02:11:40.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units granted on 01/17/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":495528,"source":{"system":"sec-edgar","filing":"0001213900-25-005675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025005675/ownership.xml","form_type":"4"}},{"id":1303348,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-15T00:16:11.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":17829,"price":11.19,"value":199506.51,"ownership":{"direct":true},"balance_after":308028,"source":{"system":"sec-edgar","filing":"0001213900-25-003534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390025003534/ownership.xml","form_type":"4"}},{"id":1518991,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-13T20:22:51.000Z","date":"2024-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":26982,"price":5.17,"value":139496.94,"ownership":{"direct":true},"balance_after":325857,"source":{"system":"sec-edgar","filing":"0000899140-24-000577","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000089914024000577/form4.xml","form_type":"4"}},{"id":1576493,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-14T12:45:21.000Z","date":"2024-03-13","kind":"purchase","planned":false,"acquired":true,"shares":13561,"price":3.74,"value":50718.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7250 to $3.7500, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":352839,"source":{"system":"sec-edgar","filing":"0000899140-24-000302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000089914024000302/form4.xml","form_type":"4"}},{"id":1677700,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-01-18T01:04:10.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":266667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":266667,"derivative":{"exercise_price":3.47,"expiration_date":"2034-01-11","underlying":"Common Stock","underlying_shares":266667},"source":{"system":"sec-edgar","filing":"0000929638-24-000131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963824000131/form4.xml","form_type":"4"}},{"id":1677699,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-18T01:04:10.000Z","date":"2024-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":13781,"price":3.47,"value":47820.07,"ownership":{"direct":true},"balance_after":339278,"source":{"system":"sec-edgar","filing":"0000929638-24-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963824000131/form4.xml","form_type":"4"}},{"id":1677698,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-18T01:04:10.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units (\"RSUs\") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":353059,"source":{"system":"sec-edgar","filing":"0000929638-24-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963824000131/form4.xml","form_type":"4"}},{"id":1784574,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-08T20:21:55.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.71,"value":37100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7099 to $3.71, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":219726,"source":{"system":"sec-edgar","filing":"0000929638-23-002490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963823002490/form4.xml","form_type":"4"}},{"id":1886723,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-18T20:49:19.000Z","date":"2023-05-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.58,"value":22900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 17, 2023, the reporting person filed a Form 4 which inadvertently included Transaction Code \"A\". The original Form 4 should have indicated Transaction Code \"P\". The reporting person has filed this amendment to restate the transaction with the correct Transaction Code."}],"balance_after":209726,"source":{"system":"sec-edgar","filing":"0000929638-23-001527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963823001527/form4.xml","form_type":"4/A","original_submission_date":"2023-05-17"}},{"id":1888738,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-17T21:35:58.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":4.58,"value":22900.0,"ownership":{"direct":true},"balance_after":209726,"source":{"system":"sec-edgar","filing":"0000929638-23-001517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963823001517/form4.xml","form_type":"4"}},{"id":1894910,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-12T22:16:14.000Z","date":"2023-05-10","kind":"tax_withholding","planned":true,"acquired":false,"shares":37443,"price":5.3,"value":198447.9,"ownership":{"direct":true},"balance_after":204726,"source":{"system":"sec-edgar","filing":"0000929638-23-001441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000092963823001441/form4.xml","form_type":"4"}},{"id":2052269,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-01-19T00:04:54.000Z","date":"2023-01-14","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":4.43,"expiration_date":"2033-01-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-23-003557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390023003557/ownership.xml","form_type":"4"}},{"id":2114411,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-16T21:56:28.000Z","date":"2022-11-15","kind":"purchase","acquired":true,"shares":20000,"price":3.82,"value":76400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.85, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":242169,"source":{"system":"sec-edgar","filing":"0001213900-22-073225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022073225/ownership.xml","form_type":"4"}},{"id":2173837,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-25T12:37:03.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":4700,"price":3.92,"value":18424.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.92, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":222169,"source":{"system":"sec-edgar","filing":"0001213900-22-050936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022050936/doc4.xml","form_type":"4"}},{"id":2267775,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-17T12:30:25.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":10000,"price":3.38,"value":33800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.36 to $3.40, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":217469,"source":{"system":"sec-edgar","filing":"0001213900-22-027450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022027450/doc4.xml","form_type":"4"}},{"id":2273378,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2022-05-12T20:30:43.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":3.38,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-22-025973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022025973/doc4.xml","form_type":"4"}},{"id":2273377,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-12T20:30:43.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":207469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Restricted Stock Units were granted on 5/10/2022. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest as follows: 50% on the first anniversary of the grant date, 30% on the second anniversary of the grant date, and the remaining 20% on the third anniversary of the grant date, subject to continued service through the applicable vesting date."}],"balance_after":207469,"source":{"system":"sec-edgar","filing":"0001213900-22-025973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390022025973/doc4.xml","form_type":"4"}},{"id":2276253,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:58:16.000Z","date":"2022-05-07","kind":"exercise","acquired":false,"shares":4442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4442},"source":{"system":"sec-edgar","filing":"0001209191-22-028164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028164/doc4.xml","form_type":"4"}},{"id":2276252,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:58:16.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":1562,"price":3.4,"value":5310.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":327194,"source":{"system":"sec-edgar","filing":"0001209191-22-028164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028164/doc4.xml","form_type":"4"}},{"id":2276251,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:58:16.000Z","date":"2022-05-07","kind":"exercise","acquired":true,"shares":4442,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":328756,"source":{"system":"sec-edgar","filing":"0001209191-22-028164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028164/doc4.xml","form_type":"4"}},{"id":2354892,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":289856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Represents a performance-based restricted stock unit grant of 144,928 target shares.  The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award.  The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number.  The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award.  Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period."}],"balance_after":289856,"derivative":{"underlying":"Class A Common Stock","underlying_shares":289856},"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354891,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":144928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on March 3, 2023."}],"balance_after":144928,"derivative":{"underlying":"Class A Common Stock","underlying_shares":144928},"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354890,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":26544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 106,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 106,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":79634,"derivative":{"underlying":"Class A Common Stock","underlying_shares":26544},"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354889,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":11111,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354888,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":9331,"price":4.45,"value":41522.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":324314,"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354887,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":26544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."}],"balance_after":333645,"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354886,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3906,"price":4.45,"value":17381.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":307101,"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2354885,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:22:08.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":11111,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."}],"balance_after":311007,"source":{"system":"sec-edgar","filing":"0001209191-22-016056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122016056/doc4.xml","form_type":"4"}},{"id":2365572,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T22:12:15.000Z","date":"2022-02-27","kind":"exercise","acquired":false,"shares":29684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 118,734 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27, 2020, the reporting person was granted 118,734 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":59367,"derivative":{"underlying":"Class A Common Stock","underlying_shares":29684},"source":{"system":"sec-edgar","filing":"0001209191-22-014150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014150/doc4.xml","form_type":"4"}},{"id":2365571,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:12:15.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":11107,"price":4.59,"value":50981.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":299896,"source":{"system":"sec-edgar","filing":"0001209191-22-014150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014150/doc4.xml","form_type":"4"}},{"id":2365570,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2022-03-01T22:12:15.000Z","date":"2022-02-27","kind":"exercise","acquired":true,"shares":29684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock."}],"balance_after":311003,"source":{"system":"sec-edgar","filing":"0001209191-22-014150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122014150/doc4.xml","form_type":"4"}},{"id":2486031,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-12-03T23:19:54.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":1500,"price":4.1,"value":6150.0,"ownership":{"direct":true},"balance_after":281319,"source":{"system":"sec-edgar","filing":"0001209191-21-067956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121067956/doc4.xml","form_type":"4"}},{"id":2718731,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:56:18.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":4441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":4442,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4441},"source":{"system":"sec-edgar","filing":"0001209191-21-031567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031567/doc4.xml","form_type":"4"}},{"id":2718730,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:56:18.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":1562,"price":5.2,"value":8122.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":282819,"source":{"system":"sec-edgar","filing":"0001209191-21-031567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031567/doc4.xml","form_type":"4"}},{"id":2718729,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-05-11T18:56:18.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":4441,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":284381,"source":{"system":"sec-edgar","filing":"0001209191-21-031567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121031567/doc4.xml","form_type":"4"}},{"id":2782824,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T20:05:27.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":36330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on May 7, 2018 and the total award of 72,661 options vests in four equal installments on May 7, 2019, May 7, 2020, May 7, 2021 and May 7, 2022."}],"balance_after":36331,"derivative":{"exercise_price":2.75,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":36330},"source":{"system":"sec-edgar","filing":"0001209191-21-021303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021303/doc4.xml","form_type":"4"}},{"id":2782823,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:05:27.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":36330,"price":6.8226,"value":247865.058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $6.82 to $6.84.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":279940,"source":{"system":"sec-edgar","filing":"0001209191-21-021303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021303/doc4.xml","form_type":"4"}},{"id":2782822,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:05:27.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":36330,"price":2.75,"value":99907.5,"ownership":{"direct":true},"balance_after":316270,"source":{"system":"sec-edgar","filing":"0001209191-21-021303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121021303/doc4.xml","form_type":"4"}},{"id":2814140,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-03-03T22:06:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":212356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period."}],"balance_after":212356,"derivative":{"underlying":"Class A Common Stock","underlying_shares":212356},"source":{"system":"sec-edgar","filing":"0001209191-21-017002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121017002/doc4.xml","form_type":"4"}},{"id":2814139,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:06:24.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":106178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2022."}],"balance_after":106178,"derivative":{"underlying":"Class A Common Stock","underlying_shares":106178},"source":{"system":"sec-edgar","filing":"0001209191-21-017002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121017002/doc4.xml","form_type":"4"}},{"id":2820588,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:39:43.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":22222,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":2820587,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:39:43.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":29683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 27,2020, the reporting person was granted 118,734 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 27,2020, the reporting person was granted 118,734 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":89051,"derivative":{"underlying":"Class A Common Stock","underlying_shares":29683},"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":2820586,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:39:43.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":3906,"price":5.18,"value":20233.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":279940,"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":2820585,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:39:43.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":11111,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock."}],"balance_after":283846,"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":2820584,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:39:43.000Z","date":"2021-02-27","kind":"tax_withholding","acquired":false,"shares":10972,"price":5.39,"value":59139.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":272735,"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":2820583,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:39:43.000Z","date":"2021-02-27","kind":"exercise","acquired":true,"shares":29683,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock units represents a contingent right to receive on share of the Issuer's Class A Common Stock."}],"balance_after":283707,"source":{"system":"sec-edgar","filing":"0001209191-21-016065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121016065/doc4.xml","form_type":"4"}},{"id":3156576,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Restricted Stock Units","published_at":"2020-05-08T23:11:53.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":4442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":8883,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4442},"source":{"system":"sec-edgar","filing":"0000899243-20-012452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/doc4.xml","form_type":"4"}},{"id":3156575,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2020-05-08T23:11:53.000Z","date":"2020-05-07","kind":"tax_withholding","acquired":false,"shares":2212,"price":3.55,"value":7852.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":254024,"source":{"system":"sec-edgar","filing":"0000899243-20-012452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/doc4.xml","form_type":"4"}},{"id":3156574,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2020-05-08T23:11:53.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":4442,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":256236,"source":{"system":"sec-edgar","filing":"0000899243-20-012452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/doc4.xml","form_type":"4"}},{"id":3233052,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T00:26:43.000Z","date":"2020-03-01","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2019, the reporting person was granted 44,444 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":33333,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11111},"source":{"system":"sec-edgar","filing":"0000899243-20-006807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/doc4.xml","form_type":"4"}},{"id":3233051,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2020-03-04T00:26:43.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":6162,"price":3.85,"value":23723.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":251794,"source":{"system":"sec-edgar","filing":"0000899243-20-006807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/doc4.xml","form_type":"4"}},{"id":3233050,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2020-03-04T00:26:43.000Z","date":"2020-03-01","kind":"exercise","acquired":true,"shares":11111,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":257956,"source":{"system":"sec-edgar","filing":"0000899243-20-006807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/doc4.xml","form_type":"4"}},{"id":3233049,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2020-03-04T00:26:43.000Z","date":"2020-02-28","kind":"purchase","acquired":true,"shares":40000,"price":3.62,"value":144800.0,"ownership":{"direct":true},"balance_after":246845,"source":{"system":"sec-edgar","filing":"0000899243-20-006807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/doc4.xml","form_type":"4"}},{"id":3238397,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2020-03-03T01:19:53.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":237468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the maximum number of shares issuable under the performance-based restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period."}],"balance_after":237468,"derivative":{"underlying":"Class A Common Stock","underlying_shares":237468},"source":{"system":"sec-edgar","filing":"0000899243-20-006637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006637/doc4.xml","form_type":"4"}},{"id":3238396,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T01:19:53.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":118734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on February 27, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on February 27, 2021."}],"balance_after":118734,"derivative":{"underlying":"Class A Common Stock","underlying_shares":118734},"source":{"system":"sec-edgar","filing":"0000899243-20-006637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320006637/doc4.xml","form_type":"4"}},{"id":3371440,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Stock Option","published_at":"2019-11-14T22:27:28.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":90498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."}],"balance_after":90498,"derivative":{"exercise_price":2.75,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":90498},"source":{"system":"sec-edgar","filing":"0001723128-19-000131","document":"wf-form4_157377043282006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/wf-form4_157377043282006.xml","form_type":"4"}},{"id":3371439,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Stock Option","published_at":"2019-11-14T22:27:28.000Z","date":"2019-11-13","kind":"disposition_to_issuer","acquired":false,"shares":90498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on March 1, 2019, and will vest in four equal annual installments beginning on March 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":90498},"source":{"system":"sec-edgar","filing":"0001723128-19-000131","document":"wf-form4_157377043282006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/wf-form4_157377043282006.xml","form_type":"4"}},{"id":3371438,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Stock Option","published_at":"2019-11-14T22:27:28.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":72661,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."}],"balance_after":72661,"derivative":{"exercise_price":2.75,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":72661},"source":{"system":"sec-edgar","filing":"0001723128-19-000131","document":"wf-form4_157377043282006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/wf-form4_157377043282006.xml","form_type":"4"}},{"id":3371437,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Stock Option","published_at":"2019-11-14T22:27:28.000Z","date":"2019-11-13","kind":"disposition_to_issuer","acquired":false,"shares":72661,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option.  The option was originally granted on May 7, 2018, and vests in four equal annual installments beginning on May 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":72661},"source":{"system":"sec-edgar","filing":"0001723128-19-000131","document":"wf-form4_157377043282006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/wf-form4_157377043282006.xml","form_type":"4"}},{"id":3530036,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2019-05-13T21:27:15.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":15000,"price":9.88,"value":148200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were acquired in multiple transactions at prices ranging from $9.65 per share to $9.99 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":205590,"source":{"system":"sec-edgar","filing":"0001723128-19-000094","document":"wf-form4_155778282066089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/wf-form4_155778282066089.xml","form_type":"4"}},{"id":3533713,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T21:45:11.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":4441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."}],"balance_after":13325,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4441},"source":{"system":"sec-edgar","filing":"0001723128-19-000091","document":"wf-form4_155743829592270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/wf-form4_155743829592270.xml","form_type":"4"}},{"id":3533712,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:45:11.000Z","date":"2019-05-07","kind":"tax_withholding","acquired":false,"shares":2228,"price":13.44,"value":29944.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":190590,"source":{"system":"sec-edgar","filing":"0001723128-19-000091","document":"wf-form4_155743829592270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/wf-form4_155743829592270.xml","form_type":"4"}},{"id":3533711,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":35632,"kind":"person","name":"Todisco Joseph","position":1,"cik":"0001774807","reported_name":"Todisco Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Specialty Commercial"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:45:11.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":4441,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":192818,"source":{"system":"sec-edgar","filing":"0001723128-19-000091","document":"wf-form4_155743829592270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/wf-form4_155743829592270.xml","form_type":"4"}}]}